SSRIs Did Not Raise Major Bleeding Risk With DOACs in Cohort Analysis
TL;DR: A 2026 study in BJGP Open found no clear cohort-level increase in major bleeding outcomes when selective serotonin reuptake inhibitors (SSRIs) were used with direct oral anticoagulants (DOACs), but the self-controlled analysis still pointed to extra cau…
Read article